University of Utah Health released a series of news updates and press releases throughout 2024. The reports cover a wide range of topics including medical research, clinical partnerships, and healthcare designations.
In research developments, a new gene therapy demonstrated an unprecedented recovery of cardiac function in a large animal model. Additionally, a drug named lenacapavir, developed by Gilead Sciences, was recognized as Science’s 2024 Breakthrough of the Year for its ability to provide protection for half a year instead of one day. Other research highlights include the discovery of a critical iron-transport protein in malaria parasites and studies regarding how spaceflight affects blood cells.
The organization announced several institutional milestones, such as University of Utah Hospital receiving the Baby-Friendly designation for the fourth time. The institution also announced the designation of the nation’s first Stillbirth Center of Excellence. Furthermore, a strategic clinical alliance was formed between CommonSpirit Health and University of Utah Health to increase patient access to medical care.
Community and public health initiatives were also documented. A five million dollar grant was launched to establish a research initiative aimed at reducing childhood obesity in six states, focusing on rural communities. Additionally, the SafeUT program reported a spike in reports regarding bullying, noting 499 emergency interventions during fiscal year 2024.
Other updates included the announcement of Valerie Vaughn, MD, MS, SFHM, FACP, as an inaugural appointee to a presidential endowed chair and the naming of Thomas K. Varghese Jr., MD, as the next Editor-in-Chief of the Journal of the American College of Surgeons.
